Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 34 n° 349

Posts Tagged ‘product’

iLOQ wins Rebuild Product Innovation award for iLOQ S5 digital locking solution

Posted by fidest press agency su giovedì, 30 settembre 2021

For almost two decades, iLOQ has been developing access management products and services that fulfill the building sector’s requirements for technological and sustainable solutions that create healthier and more energy-efficient spaces.From 256 candidates, iLOQ was recognized in the Advanced Architecture Awards 2021 for their iLOQ S5 digital locking solution. With iLOQ S5, the power for opening locks comes from the motion of inserting the key into the cylinder making batteries unnecessary and saving the environment 30,000 kg of battery waste every year. Another innovative feature of the system is device-to-device communication. A vast amount of data, such as access rights, time limitations, a list of blocked keys and audit trails, is remotely updated and then shared between readers, keys and locks in a building every time a door is opened. “I am honoured to accept this award and proud to belong to such an innovative company with a great culture and big values. Competition is intensifying in the locking industry; iLOQ is firmly at the forefront of innovation and dedicated to providing solutions that fulfill our customers’ needs now and in the future,” states Agustín Llobet, Country Manager iLOQ Iberia

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

The evolutionary financial product

Posted by fidest press agency su venerdì, 23 ottobre 2020

After the completion of the first very successful phase, in which CROWDLITOKEN AG was able to issue digital real estate bonds worth over CHF 16 million, the Liechtenstein Fintech company is once again strengthening itself with well-known names from the business world during the preparations for its next round of financing. At the beginning of this year, Remo Weibel was already announced as Chairman of the parent company CROWDLI AG and is now also involved in the evolutionary financial product of CROWDLITOKEN AG. With Michael Escher, an experienced and highly qualified manager has joined the company, who will also accompany the management in his role as delegate of the board of directors.With the election of the new Board members, the Board of Directors of CROWDLITOKEN AG and its parent company CROWDLI AG have been unified. This streamlining of structures will allow the Board of Directors to make future decisions even faster and more agile and to accelerate the implementation of the strategic orientation. The Board of Directors now consists of Ernst Sutter (Chairman), Martin Züger (Vice Chairman), Michael Escher (Delegate of the Board of Directors), Roger Bigger, Toni Caradonna, Hans Eggenberger, Hans Kuhn and Remo Weibel. The members of the Board of Directors Bruno Benaglio, Renato Fassbind, Stephan Gauer and Felix Helling are stepping down in order to streamline the Board of Directors and will continue to serve as advisors. In addition, members of the Board of Directors and the Advisory Board are underlining their confidence in CROWDLITOKEN’s forward-looking product by making further investments in the company. With the imminent publication of the online investor portal, where investors can put together their own real estate portfolio using digital real estate bonds, the next milestone is already planned for this year. CROWDLITOKEN AG is proud to be the first company in Europe to publish an investor portal of this kind and to be able to count on the confidence of the Board of Directors. “We are pleased to work with the new Board of Directors. We can also proudly look back on what we have achieved so far and would like to express our sincere thanks to the current and departing Board members”, says Domenic Kurt, CEO CROWDLITOKEN AG.

Posted in Economia/Economy/finance/business/technology, Estero/world news, Uncategorized | Contrassegnato da tag: , | Leave a Comment »

Dahua Technology Unveils Core Product Launch for 2020

Posted by fidest press agency su martedì, 21 gennaio 2020

Dahua Technology, a world leading video-centric smart IoT solution and service provider, unveils its 2020 core product launch at Intersec Dubai including the over-coax technology advancement HDCVI 6.0, AI (WizSense/WizMind) and Full-color technology which enables outstanding performance under extreme low light conditions, enabling and accelerating the AIoT transformation.
A longtime leader in HDCVI realm that offers great convenience, unparalleled quality and least cost, Dahua Technology launches HDCVI 6.0. Featuring 4K real-time (30fps live view), AI coding, two-way talk and enhanced AI, HDCVI 6.0 provides a superior visual experience where tiny details are captured with better clarity in a large monitoring coverage. Focused on human and vehicle, it significantly improves the streaming quality compared with H.265. Real-time communication allows users to warn off intruders and verify actual situations. Moreover, enhanced AI brings new possibilities to HDCVI 6.0.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

CyberPower Named a 2019 CRN Product of the Year Winner

Posted by fidest press agency su venerdì, 27 dicembre 2019

CRN®, a brand of The Channel Company, has named the Smart App Online High-Density UPS systems by Cyber Power Systems (USA), Inc., a leader in power protection and management products, a winner in the 2019 Product of the Year Awards, for Revenue and Profit in the Power Management Software and Tools category. Products and services named on the list represent best-in-class offerings based on technological innovation, financial opportunity, and customer demand. For the fourth consecutive year, winners were determined using a combination of editorial selection and a survey of solution providers who are currently selling the technology and product to capture real-world satisfaction among partners.CRN editors selected the top five finalists in 22 different product categories. Then solution providers rated each product considering a number of factors, including product quality and reliability, richness of product features and functionality, technical innovation, compatibility and ease of integration, and ability to create new customer relationships or improve existing ones. This year’s survey garnered over 5,000 responses.Mid-size and large corporations, along with education and government organizations, are among the end customer base for CyberPower’s Smart App Online High-Density UPS systems sold by value-added resellers and managed service providers in North America.The Smart App Online High-Density UPS systems are distinguished by 2U compact form factor, power factor of 1 rating, and user-friendly, LCD control panel. CyberPower launched the product line in mid-2019, available in two outputs: 5,000 VA/5,000 Watts, and 6000 VA/6,000 Watts. CRN’s 2019 Products of the Year are featured in the December issue of CRN and published online at CRN also recognized the same CyberPower product line for its innovation as a finalist in the 2019 CRN Tech Innovator Awards.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

United Health Products Completes Safety and Efficacy Animal Study for HemoStyp® Hydrocolloid Product

Posted by fidest press agency su mercoledì, 11 dicembre 2019

United Health Products (UHP) (OTC: UEEC) today announced that it had completed a safety and efficacy animal study for its HemoStyp hydrocolloid product, for which it filed a patent application in August 2019. The hemostatic hydrocolloid product is formed into a gel, foam or spray in order to control bleeding and oozing from a variety of wounds. If the patent is granted and FDA approval is obtained, HemoStyp could then be bundled as a suite of multiple products for surgical and wound care applications. UHP is also working on two other complementary HemoStyp-based products that could potentially be added to its surgical product suite.The study, A Safety and Efficacy HemoStyp Hydrocolloid Test, was done by creating bilateral femoral arteriovenous fistulas in swine. HemoStyp thrombin hydrocolloid was applied to the anastomosis suture line on one side for the cessation of bleeding, while the market leading competitive product was applied to the anastomosis suture line on the opposite side for the cessation of bleeding.
After the completed hemostatic test, an autopsy with pathologic evaluation was performed three weeks following the procedures and showed no difference in scarring and inflammation between the two hemostatic agents. Pathology was completed by Thomas J. Baldwin, DVM, PhD, DACVP Director, Utah Veterinary Diagnostic Laboratory, an affiliate of Utah State University, on November 22, 2019.The study indicated that the safety properties are equivalent to a previously approved Class III competitive product. These findings will be used to create an application for an additional format to the HemoStyp family of products and an additional Class III.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Imbed Biosciences Reveals New Brand Identity for Company and Flagship Product

Posted by fidest press agency su mercoledì, 11 dicembre 2019

Imbed Biosciences Inc. (Imbed), a privately-held biotech company emerging as a leader in the development of advanced therapies for burns, chronic ulcers, and surgical wounds, announced today the launch of its new corporate and product brand identities, redesigned logos, and websites. These changes come at a time when the company is seeing wider clinical adoption of its novel FDA-cleared next-generation antimicrobial matrix product, Microlyte® Matrix.
Microlyte® is made with bioresorbable polymers and a patented antimicrobial silver nanotechnology. Its ultrathin form factor – thinner than a human hair – allows the matrix to intimately conform to the underlying wound bed, kill bacteria hiding in deep wound tissue, and prevent biofilm colonization. The matrix is ultimately absorbed into the body, eliminating painful removal. “In the last year, Microlyte® Matrix has experienced increased usage in settings across the healthcare spectrum,” said Jeff Dalsin, PhD, Vice President of Products. “The new brand identity for Microlyte® reinforces it as the ‘go-to’ product for the management of all surgical, traumatic, and chronic wounds. The refreshed Imbed logo and color scheme speak to the company’s vision to build advanced therapies in the broad area of controlled drug delivery.” The newly redesigned website features easy-to-navigate pages for both patients and healthcare professionals with information appropriate for each audience. “We want Microlyte® website to be an educational resource for both patients and clinicians,” said Dalsin.
Imbed partnered with the team at Altabos, a Cincinnati firm, to build the brand. “The new branding represents a significant step forward in the commercial life of the company and its products. I am thrilled with the outcome of this effort and expect it to be well-received in the marketplace,” noted co-founder and CEO, Ankit Agarwal, PhD.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Health Products by Using the Medicinal Value of Red Sandalwood

Posted by fidest press agency su mercoledì, 20 novembre 2019

Pengmen International Trading Company is active in Indian red sandalwood market, focusing on the international trade of red sandalwood, the cultivation of origin and the application and development of ancient Indian medicine. The company has offices in New Delhi and Hyderabad and is qualified to trade in red sandalwood legally. The development of red sandalwood medicinal and health care products under the brand “Qian Li Mu” is a series of products developed by ayurvedic medicine of India, Chinese medicine, Nepalese medicine and international modern medicine with the vitality of red sandalwood.
In recent years, the medical community has turned its attention to red sandalwood. It was used as medicine or spice by emperors more than 2,000 years ago to treat sleep disorders, diabetes, tumors and skin diseases. With the development of modern science and technology, the active ingredient in this kind of tree was extracted. But red sandalwood is an internationally endangered species. The logs, chips, powders and extracts are tightly regulated. Experimental data shows that it can reverse the age of mammals by 40.
The development of red sandalwood medicinal and health care products under the brand “Qian Li Mu” of Pengmen International is a series of products developed by ayurvedic medicine of India, Chinese medicine, Nepalese medicine and international modern medicine with the vitality of red sandalwood. The red sandalwood cream can make people become young only through daily cleaning. Red sandalwood is also made into lipsticks, skin care products to remove wrinkles and spots on the skin. Red sandalwood toothpaste can solve dental problems through daily brushing teeth. Integrate red sandalwood into life to achieve health and longevity, which is very consistent with the current international health trend.A product called Supreme Pterostilbene (with the brand of Magicube), which is made from natural red sandalwood and has been approved by the FDA to help with memory loss and extend cell life cycle, was recently released in the United States. Recently, the company made a proposal to the Indian government, hoping that the two sides could establish a factory for the deep development and cultivation of red sandalwood in its original place to ensure the sustainable development of red sandalwood and meet the health needs of people.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

RoomIt by CWT Further Bolsters Customer Experience and Product Innovation Strategy with Two Key Appointments

Posted by fidest press agency su lunedì, 4 novembre 2019

Chicago. RoomIt by CWT™, the global hotel distribution division of CWT (the B2B4E travel management platform), announces the appointments of Jeff Zidell as Senior Vice President and Customer Experience Officer, and Ellen Zfaney, as Vice President, Supply Strategy and Innovation.“Our number one priority today, not just in RoomIt, but across our entire organization, is improving the traveler experience,” said Dave Falter, President, RoomIt by CWT. “We are excited to have Jeff and Ellen on board to build on RoomIt’s goal of delivering customer experience excellence with more relevant content, better rates and amenities, increased availability, loyalty rates, and a simple booking experience. Along with the wider RoomIt leadership team, I am delighted to welcome Jeff and Ellen, who share RoomIt’s belief that transforming your travel program to drive better compliance and results begins with a better customer experience.” Jeff joins RoomIt via startup CorePoint Lodging, where he was Senior Vice President, Asset Management. Prior to that, he spent nearly a decade with Hyatt Hotels, where he was SVP, Loyalty Marketing and Partnerships. His multi-industry background within highly competitive industries and rapidly evolving markets, position him well to lead RoomIt across all channels (Online Booking Tools, CWT TMC & RoomIt channels), and head up RoomIt’s user experience, marketing and public relations groups. He reports to Dave Falter, President, RoomIt by CWT. Ellen joins RoomIt from Expedia, where she was Head of Global Strategic Partnerships for over three years. Prior to that, she was Vice President, Americas Partnerships, Orbitz Partner Network (OPN) at Orbitz Worldwide for almost 11 years. Her RoomIt responsibility will see her lead the market management organization and the newly-created sales effectiveness global supply group. Ellen’s focus will be on positioning RoomIt’s hotel strategy and driving innovation in hotel supply channels to drive better customer experience. She will report to Shannon Hyland, Senior Vice President of Global Supply, RoomIt by CWT.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Orbital Insight Hires New Head of Product

Posted by fidest press agency su venerdì, 20 settembre 2019

Orbital Insight, the leader in geospatial analytics, today announced the addition of Jens Tellefsen to its leadership team, serving as Head of Product. Tellefsen will lead Orbital Insight’s global product vision for its recently-launched GO platform, which enables the world’s leading investors, corporates, and governments alike to make informed policy and business decisions supported by trusted geospatial analytics.Since Orbital Insight officially launched GO in May 2019, the company has experienced a surge of interest from clients seeking trusted geospatial data to analyze infrastructure, supply chains, commodities, and areas of interest pertaining to national security. Tellefsen brings over 20 years of developing world-class enterprise software products to help build out GO’s capabilities to meet the unique needs of Orbital’s diverse client base.Tellefsen has experience in enterprise software, leading companies in product strategy and management. He has led the development of scalable software solutions covering business intelligence, artificial intelligence, sales credit, and commissions management, B2B price optimization and analytics and social analytics leveraging natural language processing. Tellefsen previously served as VP of Products at Quantifind, where he led the development of the company’s predictive analytics platform. Before joining Quantifind, he served as a product executive at NetBase Solutions, Vendavo, Callidus Software, and Trilogy. He also spent two years at McKinsey & Company advising Fortune 500 companies on corporate strategy.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

The Company’s Modified Risk Tobacco Product

Posted by fidest press agency su lunedì, 22 luglio 2019

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco harm reduction, announced today that the U.S. Food and Drug Administration (FDA) accepted and filed for substantive scientific review the Company’s Modified Risk Tobacco Product (MRTP) application for its exclusive Very Low Nicotine Content (VLNC) cigarettes under the proposed brand name of VLNTM. 22nd Century’s proposed VLNTM cigarettes are made with the Company’s proprietary VLNC tobacco and, as a result, contain very low levels of nicotine. “FDA acceptance and filing of our MRTP application marks an important milestone in our mission to reduce the harm caused by smoking,” explained Michael Zercher, Chief Operating Officer of 22nd Century Group. “We look forward to working with FDA as the agency enters the next phase of its review process for our historic application.”
22nd Century is a plant biotechnology company focused on technology which allows it to decrease the level of nicotine in tobacco plants and to modify the level of cannabinoids in hemp/cannabis plants through genetic engineering and modern plant breeding. The Company’s primary mission in tobacco is to reduce the harm caused by smoking. The Company’s primary mission in hemp/cannabis is to develop proprietary hemp/cannabis plants for important new medicines and agricultural crops. Visit for more information.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

New Product Expo September 26-27 at Arlington International Racecourse

Posted by fidest press agency su domenica, 23 giugno 2019

GS Media & Events, promoters of multi-dealer RV & outdoor lifestyle shows, today announced they will host a New Product Expo preceding their upcoming Buy! Buy! Derby RV Sale in September. The Product Expo offers vendors, entrepreneurs and suppliers of innovative and new products to the RV and outdoor lifestyle market; including hunting, fishing and marine categories, the opportunity to present their products to a team of merchandise buyers and for their products to possibly be offered at over 200 Camping World and Gander Outdoors retail stores nationwide and sold on, and”The objective of our product expo is to create an efficient environment for vendors and suppliers to meet and communicate with our buyers,” said Marcus Lemonis, CEO of Camping World and Gander Outdoors and host of CNBC’s The Profit. “As we continue to grow our company throughout the United States, we are also growing our product offering and increasing our focus on finding fantastic innovative and unique products that our customers will love.” Held at the Arlington International Racecourse, at 2200 Euclid Avenue, Arlington Heights, IL, the Product Expo kicks off Thursday, September 26th from 9am-5pm and continues Friday, September 27th from 9am-12pm. Merchandise buyers will be on-site to explore many of the trends and new product opportunities being offered by established and emerging vendors. Selected product ideas will be reviewed for innovation, growth potential, design, and readiness to go-to-market. The Product Expo is free and open to all vendors, including close out products, suppliers and manufacturers that have registered to attend. More information, including the event agenda, is available here.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Fentanyl Transdermal System Due to Product Mislabeling

Posted by fidest press agency su lunedì, 22 aprile 2019

Alvogen, Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level. A small number of cartons labeled 12 mcg/h Fentanyl Transdermal System patches contained 50 mcg/h patches. The 50 mcg/h patches that were included in cartons labeled 12 mcg/h are individually labeled as 50 mcg/h. This transdermal system is manufactured by 3M Drug Delivery Systems, St. Paul, MN.Application of a 50 mcg/h patch instead of a prescribed 12 mcg/h patch could result in serious, life threatening, or fatal respiratory depression. Groups at potential increased risk could include first time recipients of such patches, children, and the elderly. To date, Alvogen Inc. has not received any reports of adverse events related to this issue.The product is indicated for the management of pain in opioid tolerant patients and is packaged in primary cartons of five individually wrapped and labeled pouches. The affected Fentanyl Transdermal System lots include:
Lot 180060 of Fentanyl Transdermal System, 12 mcg/h, expiration date 05/2020.
Lot 180073 of Fentanyl Transdermal System, 12 mcg/h, expiration date 06/2020.
The mislabeled product is packaged in a 12 mcg/h primary carton. These lots of Fentanyl Transdermal System were distributed Nationwide to the pharmacy level.Alvogen Inc. is notifying its distributors and direct customers by certified letter and is arranging for return and replacement of all recalled products. Pharmacies are requested not to dispense any product subject to this recall. Patients that have product subject to this recall should immediately remove any patch currently in use and contact their health care provider. Patients with unused product should return it to point of purchase for replacement.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Toshiba Announces Latest Ethernet Bridge IC for Automotive and Industrial Applications

Posted by fidest press agency su venerdì, 25 gennaio 2019

Toshiba America Electronic Components, Inc. (“Toshiba”) today has announced TC9562 series, its latest member in the automotive network bridge IC product line. The TC9562 series provides advanced Ethernet capability for telematics and infotainment systems for the automotive segment.Real-time processing and reliable data transmission is critical to support telematics, infotainment, driver assistance systems and various sensor data to enable a fully connected vehicle. New standards, including Ethernet AVB and TSN, are becoming adopted in automotive and industrial applications to meet the increased performance requirements.
Toshiba’s TC9562 series is designed for reliability and performance delivering Ethernet bridging capability up to 1Gbps bandwidth. The new automotive bridge IC also supports Time-Sensitive Networking (TSN) protocol for various industrial and commercial applications.The TC9562 series’s advanced capabilities supports Ethernet AVB specification, specifically IEEE 802.1AS and IEEE 802.1Qav, as well as TSN standards IEEE 802.1Qbv, IEEE 802.1Qbu[6] and IEEE 802.3br. The New IC also supports a broad range of interfaces including PCI Express® 2.0 and 1.0, I2S/TDM, RGMII, RMII, MII and an option for SGMII for expanded interfaces to various IVI SoC solutions.“We had the pleasure of working with Toshiba to feature their Ethernet bridge IC solutions in our industry-leading Qualcomm® Snapdragon™ 820A Platform,” said Shyam Krishnamurthy, senior director of Qualcomm Technologies, Inc. “We look forward to continuing our combined efforts to design cutting-edge solutions to support highly advanced automotive cockpit and telematics applications.”Shardul Kazi, Chief Marketing Officer at Toshiba America Electronic Components, Inc., commented, “We are pleased to expand the successful automotive Ethernet bridge IC series to the market. We hope to help accelerate the Ethernet adoption in automotive applications.”The TC9562 series will be automotive qualified[8] and packaged in P-LFBGA120 in 9mm x 9mm package. Sample shipments will start in February 2019, and volume production will start in October 2019.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Cloudinary Announces Significant Growth Milestones and Product Momentum

Posted by fidest press agency su venerdì, 12 ottobre 2018

Cloudinary announced significant growth milestones including major new strategic partnerships and rapid demand for its new Digital Asset Management (DAM) solution, first unveiled in June. The company’s end-to-end DAM solution automates the entire media management lifecycle at scale, accelerates time to market, and optimizes the end user experience across all touchpoints. Cloudinary also introduced new DAM capabilities including an expanded media library with flexible sharing and collaboration capabilities that make it easy to control access to assets throughout their entire lifecycle and across all content, brand and developer teams.“Our secondary ticket marketplace is the largest in the world and Cloudinary has been instrumental in our ability to easily and efficiently manage our media assets for the millions of fans relying on our platform every day,” said Susan Stigelitz, Head of Imagery at StubHub. “We’d been utilizing Cloudinary’s image and video management capabilities for months and adopting its digital asset management solution was a natural choice as it will allow our diverse teams to have a single source of truth for our media that makes it easy to collaborate and bridge big efficiency gaps. The Cloudinary team has been a trusted tech partner and we look forward to continued success in the months ahead.”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Destination Maternity Hires Great American Group to Help Rationalize Inventory and Product Cycle

Posted by fidest press agency su venerdì, 5 ottobre 2018

Destination Maternity Corporation (NASDAQ: DEST) (the “Company”) announced today that it has retained Great American Group to assist the Company in the strategic rationalization of its overall store inventory and product cycle.Marla Ryan, the CEO of Destination Maternity commented, “We remain committed to finding efficiencies across our cost structure. To that end, we welcome the opportunity to work with Great American Group to assist us in maximizing inventory efficiency, including reducing lower-performing inventory while investing in higher velocity items across our store base.“In conjunction with the expected $76 million refinancing facility with Bank of America, we believe the engagement with Great American Group will help to improve our product cycle, rationalize inventory levels and further strengthen our capital base going forward.”Based in Woodland Hills, CA, Great American Group serves as a leading provider of asset disposition and valuation and appraisal services to a wide range of retail, wholesale and industrial clients.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Biotecnologie: è difficile stare al passo con il loro progresso

Posted by fidest press agency su mercoledì, 2 Maggio 2018

A cura di:Marie-Laure Schaufelberger, Product Specialist del fondo Pictet-Biotech di Pictet Asset Management. Le società farmaceutiche stanno perdendo terreno nei confronti di un nuovo tipo di produttori farmaceutici. Mentre le case farmaceutiche producono medicinali partendo dalle sostanze chimiche, le società biotecnologiche utilizzano organismi viventi come batteri o enzimi per i loro prodotti. Inoltre, una più profonda comprensione del DNA umano ha consentito alle società biotecnologiche di affrontare malattie specifiche con molta più precisione rispetto alle società farmaceutiche tradizionali. Il settore ha un tasso di crescita stimato del 15-20% annuo. Questo rappresenta un tasso di crescita previsto del 6% per le vendite di farmaci con prescrizione a livello mondiale per il periodo fino al 2022. Oltre 700 società biotecnologiche sono attualmente quotate sui mercati azionari internazionali. I ricavi totali delle società biotecnologiche quotate sono cresciuti di sette volte dal 2000 al 2016, passando da poco più di 20 a quasi 140 miliardi di dollari.Le società biotecnologiche hanno già raggiunto risultati considerevoli. ‘Un buon esempio è la cura per l’epatite C, che è stata messa a punto da un’importante società biotecnologica americana’, afferma Marie-Laure Schaufelberger, Product Specialist del fondo Pictet-Biotech. Tuttavia, il prezzo di questa cura è alto. Un trattamento della durata di tre mesi può costare dai 70.000 ai 100.000 dollari. Dozzine di società biotecnologiche hanno uno o più prodotti nella fase finale di sviluppo clinico che precede l’approvazione della FDA, l’ente governativo americano che si occupa della regolamentazione dei prodotti alimentari e farmaceutici.
Nell’ambito farmaceutico tradizionale, quando il brevetto di un farmaco di successo scade, un timore diffuso per il produttore è che le società che realizzano farmaci generici ne riproducano la formula commercializzandola a un prezzo significativamente scontato. Dato che i brevetti dell’Aspirina sono in circolazione da parecchio tempo, altre società oltre alla Bayer, che l’ha inventata, sono autorizzate a produrre e vendere questo farmaco. Ciò spiega perché una compressa costa solo pochi centesimi. La società di consulenza EvaluatePharma stima che le società farmaceutiche sono destinate a perdere ricavi pari a quasi 80 miliardi di dollari tra il 2017 e il 2020 per via dell’aumento della concorrenza. Per le società biotecnologiche, questo rischio è notevolmente minore. ‘Chiunque voglia produrre una medicina simile a un farmaco biotecnologico il cui brevetto è scaduto – noto anche come farmaco biosimilare – deve innanzitutto dimostrare che il prodotto presenta esattamente le stesse caratteristiche biologiche del trattamento originale’, spiega Schaufelberger. ‘Una procedura molto più complessa rispetto a quella dei farmaci tradizionali, per i quali è sufficiente dimostrare che la composizione chimica è simile.’
Negli Stati Uniti, le società che intendono commercializzare la versione generica di un farmaco biotecnologico il cui brevetto è scaduto devono superare un altro ostacolo. ‘Questi farmaci devono superare test clinici, simili a quelli del farmaco biotecnologico originale’, afferma Schaufelberger. ‘Oltre a un capitale e conoscenze importanti, occorreranno laboratori di alta qualità per produrre in modo sicuro ed efficiente farmaci generici ed essere competitivi con un prodotto di successo, una volta scaduto il brevetto. Tra le società che possiedono tutti questi asset figurano molte grandi società biotecnologiche. Se giocano bene le loro carte, crediamo che abbiano il potenziale per attingere a una nuova fonte di reddito. Riteniamo che le dinamiche del settore biotecnologico lo rendano un’area di investimento interessante.’

Posted in Medicina/Medicine/Health/Science, Spazio aperto/open space | Contrassegnato da tag: , , | Leave a Comment »

Indix Announces Broad Availability of Its AI-Based Product Prediction Services

Posted by fidest press agency su martedì, 20 febbraio 2018

Indix, the world’s leading product AI company, announced the broad availability of its AI-based prediction services for product categorization, brand identification, standardized attribute extraction and product clustering. With Indix’s prediction services, companies will now have the power to process millions of product records in minutes, using AI, without any humans in the loop.
Using Indix prediction services, ecommerce marketplaces can clean and verify seller content and augment product listing attributes. Etailers can clean and verify existing content and accelerate SKU onboarding. Adtech companies can standardize advertiser catalogs, enhance ad relevance and power dynamic ads. Affiliates and Publishers can automate catalog management and power product search. Market Research and Analytics companies can identify and classify products using just the limited information on electronic receipts.“From the very beginning we invested in AI and ML because there was no other way to handle the amount of product information that we were processing every day,” said Sanjay Parthasarathy, founder and CEO of Indix Corporation. “As a result, we have built a completely automated product information platform that learns continuously.” Indix has used all four prediction services along with its search ranking and relevance to power the recently released Samsung Mall, to enable consumers to discover and buy products across multiple online shopping sites in India using Samsung smartphones’ cameras, microphones and key inputs.“We have over two billion product offers on our platform and we built AI-based services to automate our own catalog management,” said Sri Velamoor, VP of Sales and Business Development at Indix. “Over time, our algorithms have leveraged these billions of data points to learn a normalized taxonomy and schema and compile a brand dictionary, all of which helped standardize our catalog. Indix is excited to offer these prediction services and metadata to companies that want to improve their product catalogs or structure their product information.”Indix’s AI-based prediction services, combined with metadata and product content, helps companies automate and accelerate their vision for next generation shopping, advertising, IoT and analytics.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Catella: Strategic Real Estate Allocation survey shows new real estate vehicles emerging

Posted by fidest press agency su venerdì, 8 dicembre 2017

catella LichtenbergIn the latest Catella Market Tracker, “Strategic Real Estate Allocation – on its way into new product dimensions?”, the top100 multi-asset managers in Germany were asked what strategic real estate allocation course they will set over the coming months in the on-going real estate boom.The survey of the top 100 multi-asset managers revealed the following:
– 57% of the asset managers surveyed expect an appearance of real estate ETFs on the German market in 2019–2022, while only 13% do not expect a positioning of this product.
– Real estate secondaries and real estate multi-manager funds seem to be a particular future investment option. Of those surveyed, 20 % would invest 4–6 % in real estate secondaries, 7.7 % in multi-manager funds.
– Private equity investments would also profit from an adjustment if key interest rates rise, and would take an additional 10% share of investor allocation. The yield expectation is beyond 10%.
– Exchange traded funds experience an adjustment of 5 % in asset allocation, and could record an average yield of 3 %.“Tactical aspects continue to be expressed in the presented sentiment analysis, especially expansion towards the vehicles of real estate secondaries, and ETFs in the past 20 months seem to be more than a vision,” says Dr. Thomas Beyerle, Head of Group Research, regarding the results of the survey. “An attack on specialist funds does not seem to be happening here,” adds Beyerle. In the coming years, Catella Research therefore expects an increase in the market volume of alternative real estate products, even if only by a very low degree. Greater acceptance of the real-estate-based financial products of multi-asset managers with yield expectations quite a bit “beyond the 5” is shown.The complete Market Tracker is available at

Posted in Economia/Economy/finance/business/technology, Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

DuPont Pioneer Announces Intentions to Commercialize First CRISPR-Cas Product

Posted by fidest press agency su mercoledì, 20 aprile 2016

dupontJOHNSTON, Iowa – DuPont Pioneer announced waxy corn hybrids as its first commercial agricultural product developed through the application of CRISPR-Cas enabled advanced breeding technology. This next generation of elite waxy corn hybrids is expected to be available to U.S. growers within five years, pending field trails and regulatory reviews.”We’re applying our 90 years of knowledge of corn biology to develop the next generation of high-quality waxy corn hybrids for the benefit of the entire value chain from growers to processors and end users,” said Neal Gutterson, vice president, research and development for DuPont Pioneer. “Starting with an identity-preserved product as our initial CRISPR-Cas offering allows us to lay a solid foundation for success of future larger volume products from this plant breeding innovation.” Pioneer is the leading supplier of waxy corn hybrids globally. In the United States, about a half-million acres of waxy corn are grown each year; however, they traditionally yield less than non-waxy corn hybrids. Waxy corn produces a high amylopectin starch content, which is milled for a number of everyday consumer food and non-food uses including processed foods, adhesives and high-gloss paper. Waxy corn is typically grown on contract through a closed-loop production system commonly referred to as “identity-preserved”.
Johnston“The next generation of waxy hybrids developed with CRISPR-Cas will represent a step-change in how efficiently we bring elite genetic platforms of high-yielding waxy corn to our customers,” Gutterson said.The United States Department of Agriculture (USDA) recently published its response to Pioneer’s “Regulated Article Letter of Inquiry” stating that it does not consider next-generation waxy corn developed with CRISPR-Cas enabled advanced breeding technology as regulated by USDA Biotechnology Regulatory Services.”DuPont Pioneer believes that CRISPR-Cas as an advanced plant breeding tool holds great promise for maintaining the world’s ability to produce an abundant and healthy food supply. The USDA’s confirmation is an important first step toward clarifying the U.S. regulatory landscape and the development of seed products with CRISPR-Cas technology,” said Gutterson. “We continue to consult with global regulatory bodies and government agencies in order to understand the potential regulations around the world.”Pioneer is establishing a CRISPR-Cas enabled advanced breeding platform to develop seed products for greater environmental resiliency with characteristics like disease resistance and drought tolerance, in addition to advancing the development of improved hybrid systems. The technology has applicability for all Pioneer crops of interest.”This is just the beginning: We believe the true value of this important innovation in plant breeding will be achieved through active engagement with customers, academia, governments, NGOs and public research institutes to develop new solutions to the toughest agricultural challenges,” added Gutterson. “Pioneer has a long history of collaboration and broadly advancing science and is open to entering further collaborations which would contribute to developing CRISPR-Cas technology across all crops and geographies for the greater good.” Pioneer previously announced strategic agreements for research collaborations and intellectual property (IP) licenses with Vilnius University and with Caribou Biosciences. These are combined with DuPont’s own IP, technology capabilities, infrastructure and scientific expertise that are being applied in order to advance CRISPR-Cas.

Posted in Estero/world news, Spazio aperto/open space | Contrassegnato da tag: , , | Leave a Comment »

Altair’s TD-LTE Chipset Selected by Olive Telecom, India’s leading Convergence Solutions Device Developer

Posted by fidest press agency su venerdì, 11 Maggio 2012

Hod Hasharon, Israel, (PRNewswire) Altair Semiconductor (, a leading developer of ultra-low power, small footprint and high performance 4G LTE chipsets, today announced that its ‘Hornet’ TD-LTE chipset, recently introduced to the Indian market, has been selected by Olive Telecom to power Olive’s line of LTE enabled products. Olive Telecom is a world class designer and supplier of wireless devices, 2G/3G mobile handsets and smart phones, connected mobile computing devices and advanced data modems.”We are very pleased to have been selected by a leading designer and supplier of mobile and portable devices such as Olive for use in their products,” said Eran Eshed, Co-Founder and VP of Marketing and Business Development at Altair. “Olive’s selection of Altair reaffirms the leadership position Altair has built in the Indian market. We look forward to building on our partnership with Olive and continuing to expand our footprint in the Indian market.” “Altair’s LTE solution was a natural choice for us to integrate into our 4G enabled devices, customized for the Indian market,” said Artem Orange, President Operations at Olive. “The combination of maturity, performance and cost will enable Olive to differentiate our products and shorten our time to market.”Altair is a market leader in the global TD-LTE industry. Altair-based products are commercially deployed in Brazil and the Company has completed advanced pre-commercial field trials with carriers around the world, including Softbank in Japan, China Mobile and leading carriers in India. Altair’s TD-LTE solution is the first to have demonstrated Category 4 throughputs publically in China and Japan.
Altair Semiconductor is the world’s leading developer of ultra-low power, small footprint and high performance 4G semiconductors. Altair’s chipsets can be found in approximately 30 end-user devices – ranging from USB dongles to smartphones – built by its more than 15 customers across North America, Europe, China, India and Taiwan – making it one of the only TDD/FDD LTE chipset manufacturers in the world with commercially available products. Altair’s comprehensive product portfolio includes baseband processors, multi-band RF transceivers for both FDD and TDD bands, and a range of reference hardware and product level protocol stack software. Based on a novel, proprietary Software Defined Radio (SDR) processor, codenamed “O[2]P™”, Altair’s products are the smallest and most highly power optimized in the industry, offering an unmatched combination of flexibility and performance. For more information, visit the company’s website at Follow Altair on Twitter: @AltairSemi

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »